At NovalGen, fostering open dialogue and transparent communication with patient organisations is integral to our commitment to patients and caregivers. Recognising the invaluable insights and perspectives they offer, patient organisations serve as vital partners in our decision-making processes across the entire lifecycle of our medicines. We are dedicated to actively engaging with these organisations, ensuring that their voices are heard and their needs are addressed as we continue our mission to find innovative solutions that change the lives of patients worldwide.

More in this section

Clinical trials

NovalGen is committed to developing innovative treatments.

Read more

About disease areas

Unmet Need in chronic lymphocytic leukemia and mantle cell lymphoma

Read more